Drug delivery system targeting advanced hepatocellular carcinoma: Current and future

Nanomedicine : Nanotechnology, Biology, and Medicine
Xue ZhangHongqi Zhang

Abstract

Hepatocellular carcinoma (HCC) has a fairly high morbidity and is notoriously difficult to treat due to long latent period before detection, multidrug resistance and severe drug-related adverse effects from chemotherapy. Targeted drug delivery systems (DDS) that can selectively deliver therapeutic drugs into tumor sites have demonstrated a great potential in cancer treatment, which could be utilized to resolve the limitations of conventional chemotherapy. Numerous preclinical studies of DDS have been published, but targeted DDS for HCC has yet to be made for practical clinical use. Since rational targeted DDS design should take cancer-specific properties into consideration, we have reviewed the biological and physicochemical properties of HCC extensively to provide a comprehensive understanding on HCC, and recent DDS studies on HCC, aiming to find some potential targeted DDSs for HCC treatment and a meaningful platform for further development of HCC treatments. Hepatocellular carcinoma has a high incidence worldwide and is known to be multidrug resistant. Thus, intensive research is being carried out to find better chemotherapeutic agents as well as new drug delivery systems. In this article, the authors reviewed in depth the c...Continue Reading

References

Jul 1, 1991·Biochimica Et Biophysica Acta·M NegishiA Ichikawa
Mar 30, 1990·Biochemical and Biophysical Research Communications·I KovalszkyR V Iozzo
Jan 1, 1990·Pharmacology & Therapeutics·F Ballet
Apr 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H TakahashiJ Wands
Sep 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W W Lautt, C V Greenway
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·R SutherlandM Greaves
Jan 1, 1982·Annual Review of Biochemistry·G Ashwell, J Harford
Mar 1, 1982·Collagen and Related Research·M Rojkind, P Ponce-Noyola
Jan 1, 1993·Journal of Surgical Oncology·K IsshikiH Takagi
May 1, 1996·The Journal of Pathology·J MathewA D Burt
Aug 9, 1996·Molecular and Cellular Endocrinology·R Matsushima-NishiwakiY Muto
Sep 19, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M HashidaY Takakura
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Mar 1, 2000·Molecular Pathology : MP·S GoodisonD Tarin
Apr 7, 2000·The American Journal of Pathology·H HashizumeD M McDonald
Jun 2, 2000·Biochemical and Biophysical Research Communications·S K YoonJ R Wands
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·V P Torchilin
Feb 13, 2001·Journal of Pharmaceutical Sciences·S KawakamiM Hashida
Apr 3, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·O MussoB Clement
May 1, 2001·Critical Reviews in Therapeutic Drug Carrier Systems·S P VyasV Sihorkar
Aug 24, 2001·The Journal of Clinical Investigation·J Filmus, S B Selleck
Nov 10, 2001·Annual Review of Biomedical Engineering·R K Jain
Dec 13, 2002·International Journal of Cancer. Journal International Du Cancer·Yutaka MidorikawaHiroyuki Aburatani
Jun 6, 2003·Biochemical and Biophysical Research Communications·Tetsuya NakatsuraYasuharu Nishimura
Jul 10, 2003·Gastroenterology·Mariana CapurroJorge Filmus
Dec 12, 2003·Cancer Cell·Marsha A MosesRobert Langer
Feb 21, 2004·Biochemical and Biophysical Research Communications·Eunyoung Chun, Ki-Young Lee
Mar 20, 2004·Science·Theresa M Allen, Pieter R Cullis
Jul 13, 2004·Journal of Hepatology·Michael BläkerAndreas De Weerth
Jul 16, 2004·Seminars in Radiation Oncology·Peter Vaupel
Jul 16, 2004·Seminars in Radiation Oncology·Michael MilosevicRichard Hill

❮ Previous
Next ❯

Citations

Jul 7, 2016·Molecular and Cellular Probes·Yiming LiuChuansheng Zheng
Mar 31, 2017·Journal of Biomaterials Science. Polymer Edition·Nivishna VenkatrajSandrine Cammas Marion
Jun 18, 2017·Medicinal Research Reviews·Fubo ZhouJie Tian
Nov 7, 2018·Cell Proliferation·Mubalake AbudoureyimuXiaoyuan Chu
May 29, 2020·Journal of Biomaterials Science. Polymer Edition·Zeynep KarahalilogluBaki Hazer
Feb 28, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Zhiman BaiWei Huang
Jul 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xue ZhangHong-Qi Zhang
Dec 6, 2017·International Journal of Oncology·Chien-Hsun WuHan-Chung Wu
Feb 26, 2020·Cancers·Manali Dimri, Ande Satyanarayana
Dec 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anroop B NairKatharigatta N Venugopala
Feb 6, 2017·Drug Delivery·Sandhya PranatharthiharanPadma V Devarajan
Nov 11, 2020·Drug Development Research·Selvaraj KunjiappanPanneerselvam Theivendren
Dec 10, 2020·Expert Opinion on Drug Delivery·Vikas KumarHyung Sik Kim
Jun 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhe MaZhidong Liu
Jan 13, 2021·Drug Delivery and Translational Research·Sachin S BhatBanala Venkatesh Teja
Oct 23, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Haroon IqbalHuabing Chen
Dec 15, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hongzhi WangPeixuan Guo
Oct 30, 2020·International Journal of Nanomedicine·Artur JędrzakRadosław Mrówczyński
Aug 3, 2021·Frontiers in Oncology·Pin ZhaoShaojun Xing

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Artificial Cells, Nanomedicine, and Biotechnology
Maryam HosseiniMehdi Yousefi
Yao xue xue bao = Acta pharmaceutica Sinica
Yuan-Yuan DiaoJian-Qing Gao
Biochimica Et Biophysica Acta
Shun-rong JiXian-jun Yu
Technology in Cancer Research & Treatment
J Zhong, L C Dai
© 2022 Meta ULC. All rights reserved